Your browser doesn't support javascript.
loading
Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors.
Martin, Sara E S; Tan, Zhi-Wei; Itkonen, Harri M; Duveau, Damien Y; Paulo, Joao A; Janetzko, John; Boutz, Paul L; Törk, Lisa; Moss, Frederick A; Thomas, Craig J; Gygi, Steven P; Lazarus, Michael B; Walker, Suzanne.
Afiliação
  • Martin SES; Department of Microbiology , Harvard Medical School , Boston , Massachusetts 02115 , United States.
  • Tan ZW; Department of Microbiology , Harvard Medical School , Boston , Massachusetts 02115 , United States.
  • Itkonen HM; Department of Microbiology , Harvard Medical School , Boston , Massachusetts 02115 , United States.
  • Duveau DY; Division of Preclinical Innovation, National Center for Advancing Translational Sciences , National Institutes of Health , Bethesda , Maryland 20892 , United States.
  • Paulo JA; Department of Cell Biology , Harvard Medical School , Boston , Massachusetts 02115 , United States.
  • Janetzko J; Department of Microbiology , Harvard Medical School , Boston , Massachusetts 02115 , United States.
  • Boutz PL; Department of Chemistry and Chemical Biology , Harvard University , Cambridge , Massachusetts 02138 , United States.
  • Törk L; The David H. Koch Institute for Integrative Cancer Research , Massachusetts Institute of Technology , Cambridge , Massachusetts 02139 , United States.
  • Moss FA; Department of Chemistry and Chemical Biology , Harvard University , Cambridge , Massachusetts 02138 , United States.
  • Thomas CJ; Department of Microbiology , Harvard Medical School , Boston , Massachusetts 02115 , United States.
  • Gygi SP; Division of Preclinical Innovation, National Center for Advancing Translational Sciences , National Institutes of Health , Bethesda , Maryland 20892 , United States.
  • Lazarus MB; Department of Cell Biology , Harvard Medical School , Boston , Massachusetts 02115 , United States.
  • Walker S; Department of Pharmacological Sciences , Icahn School of Medicine at Mount Sinai , New York , New York 10029 , United States.
J Am Chem Soc ; 140(42): 13542-13545, 2018 10 24.
Article em En | MEDLINE | ID: mdl-30285435
ABSTRACT
Reversible glycosylation of nuclear and cytoplasmic proteins is an important regulatory mechanism across metazoans. One enzyme, O-linked N-acetylglucosamine transferase (OGT), is responsible for all nucleocytoplasmic glycosylation and there is a well-known need for potent, cell-permeable inhibitors to interrogate OGT function. Here we report the structure-based evolution of OGT inhibitors culminating in compounds with low nanomolar inhibitory potency and on-target cellular activity. In addition to disclosing useful OGT inhibitors, the structures we report provide insight into how to inhibit glycosyltransferases, a family of enzymes that has been notoriously refractory to inhibitor development.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / N-Acetilglucosaminiltransferases / Inibidores Enzimáticos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / N-Acetilglucosaminiltransferases / Inibidores Enzimáticos Idioma: En Ano de publicação: 2018 Tipo de documento: Article